Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shanna Huang
Tumor-Derived Exosomal miR-1247-3p Induces Cancer-Associated Fibroblast Activation to Foster Lung Metastasis of Liver Cancer
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Cyclin D1 Induction by Benzo[a]pyrene-7,8-Diol-9,10-Epoxide via the Phosphatidylinositol 3-Kinase/Akt/Mapk- And P70s6k-Dependent Pathway Promotes Cell Transformation and Tumorigenesis
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
Exosomal miR-25-3p Derived From Hypoxia Tumor Mediates IL-6 Secretion and Stimulates Cell Viability and Migration in Breast Cancer
RSC Advances
Chemistry
Chemical Engineering
Corrigendum: Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26
Frontiers in Immunology
Allergy
Immunology
Studying Primary Tumor–associated Fibroblast Involvement in Cancer Metastasis in Mice
Nature Protocols
Biochemistry
Genetics
Molecular Biology
MiR-19-3p Induces Tumor Cell Apoptosis via Targeting FAS in Rectal Cancer Cells
Technology in Cancer Research and Treatment
Medicine
Cancer Research
Oncology
miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
miR-193a-3p Functions as a Tumor Suppressor in Lung Cancer by Down-Regulating ERBB4
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
miR-203 Facilitates Tumor Growth and Metastasis by Targeting Fibroblast Growth Factor 2 in Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
MiR-590-3p Promotes Proliferation and Metastasis of Colorectal Cancer via Hippo Pathway
Oncotarget
Oncology
miR‑144‑3p Regulates the Resistance of Lung Cancer to Cisplatin by Targeting Nrf2
Oncology Reports
Medicine
Cancer Research
Oncology